基于质谱的DNA加合物组技术在药学领域应用的研究进展

闫明，叶倩，王雪，文海若; YAN Ming; YE Qian; WANG Xue; WEN Hairuo

温馨提示：建议您使用Chrome80、火狐74+、IE9+浏览器，当您的浏览器版本过低，可能会影响部分功能正常使用。

主办：天津药物研究院中国药学会

微信公众号

网站二维码

2025年6月15日 1:30 星期日

首页 > 过刊浏览>2021年第44卷第4期 >2021,44(4):876-884. DOI:10.7501/j.issn.1674-6376.2021.04.030

基于质谱的DNA加合物组技术在药学领域应用的研究进展

闫明
闫明
中国药科大学, 江苏南京 211198;中国食品药品检定研究院国家药物安全评价监测中心, 药物非临床安全性评价研究北京市重点实验室, 北京 100176
在期刊界中查找
在Google Scholar中查找
在百度中查找
在PubMed中查找
在本站中查找
叶倩
叶倩
中国药科大学, 江苏南京 211198;中国食品药品检定研究院国家药物安全评价监测中心, 药物非临床安全性评价研究北京市重点实验室, 北京 100176
在期刊界中查找
在Google Scholar中查找
在百度中查找
在PubMed中查找
在本站中查找
王雪
王雪
中国食品药品检定研究院国家药物安全评价监测中心, 药物非临床安全性评价研究北京市重点实验室, 北京 100176
通讯作者.
Email: xue_wang@nifdc.org.cn
在期刊界中查找
在Google Scholar中查找
在百度中查找
在PubMed中查找
在本站中查找
文海若
文海若
中国食品药品检定研究院国家药物安全评价监测中心, 药物非临床安全性评价研究北京市重点实验室, 北京 100176
通讯作者.
Email: wenhairuo@nifdc.org.cn
在期刊界中查找
在Google Scholar中查找
在百度中查找
在PubMed中查找
在本站中查找

Research progress in application of mass spectrometry-based DNA adduct technology in field of pharmacy

YAN Ming
YAN Ming
China Pharmaceutical University, Nanjing 211198, China;National Center for Safety Evaluation of Drugs, National Institutes for Food and Drug Control, Key Laboratory of Beijing for Nonclinical Safety Evaluation Research of Drugs, Beijing 100176, China
在期刊界中查找
在Google Scholar中查找
在百度中查找
在PubMed中查找
在本站中查找
YE Qian
YE Qian
China Pharmaceutical University, Nanjing 211198, China;National Center for Safety Evaluation of Drugs, National Institutes for Food and Drug Control, Key Laboratory of Beijing for Nonclinical Safety Evaluation Research of Drugs, Beijing 100176, China
在期刊界中查找
在Google Scholar中查找
在百度中查找
在PubMed中查找
在本站中查找
WANG Xue
WANG Xue
National Center for Safety Evaluation of Drugs, National Institutes for Food and Drug Control, Key Laboratory of Beijing for Nonclinical Safety Evaluation Research of Drugs, Beijing 100176, China
Contact Author.
Email: xue_wang@nifdc.org.cn
在期刊界中查找
在Google Scholar中查找
在百度中查找
在PubMed中查找
在本站中查找
WEN Hairuo
WEN Hairuo
National Center for Safety Evaluation of Drugs, National Institutes for Food and Drug Control, Key Laboratory of Beijing for Nonclinical Safety Evaluation Research of Drugs, Beijing 100176, China
Contact Author.
Email: wenhairuo@nifdc.org.cn
在期刊界中查找
在Google Scholar中查找
在百度中查找
在PubMed中查找
在本站中查找

发布日期：2021-04-07

摘要
图/表
访问统计
PDF预览
参考文献
相似文献
引证文献
附件

[关键词]

DNA加合物 ; 加合物组学 ; 质谱 ; 致癌物

[摘要]

DNA加合物是评价DNA损伤最直接的分子证据，随之产生一个专门研究DNA修饰识别和DNA加合物定量的新领域——DNA加合物组学。其中质谱（MS）分析法是常用的DNA加合物组学技术，并且随着质谱分析仪的灵敏度和扫描速度的提高，使得利用DNA加合物组学技术来筛查人类基因组中DNA损伤成为可能。其中，基于质谱技术对马兜铃、巴豆醛等致癌物生成的DNA加合物的种类的检测应用十分广泛。主要就基于质谱的加合物组学检测技术及其在致癌物检测中的应用进行概述。

[Key word]

DNA adduct ; DNA adductomics ; MS ; carcinogens

[Abstract]

DNA adducts are the most direct molecular evidence for evaluating DNA damage, and a new field specializing in DNA modification recognition and DNA adduct quantification—DNA adductomics has emerged.Mass spectrometry (MS) is a commonly used DNA adductomics technology, and with the increase in the sensitivity and scanning speed of mass spectrometry, the use of DNA adductomics technology to screen DNA in the human genome Damage becomes possible. The detection of DNA adducts produced by carcinogens such as aristolochia and crotonaldehyde based on mass spectrometry is very widely used. This article mainly summarizes the adductomics detection technology based on mass spectrometry and its application in the detection of carcinogens.

[中图分类号]

R917

[基金项目]

国家“重大新药创制”科技重大专项（2018ZX09201017-001）；中国食品药品检定研究院学科带头人培养基金资助项目（2019X4）

引用本文 / Get Citation

闫明,叶倩,王雪,文海若.基于质谱的DNA加合物组技术在药学领域应用的研究进展[J].药物评价研究,2021,44(4):876-884

分享 / Share

文章指标 / Article Metrics

点击次数: 1435

下载次数: 1777

Html阅读次数: 0

引用次数: 0

历史 / History

收稿日期: 2020-10-15

在线发布日期: 2021-04-07

[1] Loeb L A, Harris C C.Advances in chemical carcinogenesis:a historical review and prospective[J]. Cancer Res, 2008, 68(17):6863-6872.

[2] Grollman A P.Aristolochic acid nephropathy:harbinger of a global iatrogenic disease[J]. Environ Mol Mutag, 2013, 54(1):1-7.

[3] Jarabek A M, Pottenger L H, Andrews L S, et al.Creating context for the use of DNA adduct data in cancer risk assessment:I.data organization[J]. Crit Rev Toxicol, 2009, 39(8):659-678.

[4] Matsuda T, Tao H, Goto M, et al.Lipid peroxidationinduced DNA adducts in human gastric mucosa[J]. Carcinogenesis, 2013, 34(1):121-127.

[5] Liu S, Wang Y.Mass Spectrometry for the assessment of the occurrence and biological consequences of DNA adducts[J]. Chem Soc Rev, 2015, 44(21):7829-7854.

[6] Guo J, Turesky R J.Emerging technologies in mass spectrometry-based DNA adductomics[J]. HighThroughput, 2019, 8(2):13.

[7] Tretyakova N, Goggin M, Sangaraju D, et al.Quantitation of DNA adducts by stable isotope dilution mass spectrometry[J]. Chem Res Toxicol, 2012, 25:2007-2035.

[8] Hoffmann E, Stroobant V.Mass Spectrometry Principles and Applications[M]. West Sussex, UK:John Wiley&Sons Ltd, 2007.

[9] Wolf S M, Vouros P.Application of capillary liquid chromatography coupled with tandem mass spectrometric methods to the rapid screening of adducts formed by the reaction of N-acetoxy-N-acetyl-2-aminofluorene with calf thymus DNA[J]. Chem Res Toxicol, 1994, 7(1):82-88.

[10] Kanaly R A, Matsui S, Hanaoka T, et al.Application of the adductome approach to assess intertissue DNA damage variations in human lung and esophagus[J]. Mutat Res, 2007, 625(1):83-93.

[11] Tretyakova N, Villalta P W, Kotapati S.Mass spectrometry of structurally modified DNA[J]. Chem Rev, 2013, 113(4):2395-2436.

[12] Douglas D J, Frank A J, Mao D.Linear ion traps in mass spectrometry[J]. Mass Spectr Rev, 2005, 24(1):1-29.

[13] Gérard H, Husser C, Zell M.Rapid screening and characterization of drug metabolites using a new quadrupole-linear ion trap mass spectrometer[J]. J Mass Spectr, 2003, 38(2):138-150.

[14] Chowdhury G, Guengerich F P.Direct detection and mapping of sites of base modification in DNA fragments by tandem mass spectrometry[J]. Angewandte Chem Int Ed, 2008, 47(2):381-384.

[15] Qin J, Chait B T.Identification and characterization of posttranslational modifications of proteins by MALDI ion trap mass spectrometry[J]. Anal Chem, 1997, 69(19):4002-4009.

[16] Bessette E E, Goodenough A K, Langoue T S, et al.Screening for DNA adducts by data-dependent constant neutral loss-triple stage mass spectrometry with a linear quadrupole ion trap mass spectrometer[J]. Anal Chem, 2009, 81(2):809-819.

[17] Pietsch K E, van Midwoud P M, Villalta P W, et al.Quantification of acylfulvene and illudin S DNA adducts in cells with variable bioactivation capacities[J]. Chem Res Toxicol, 2013, 26(1):146-155.

[18] Hager J W, Blanc J C.Product ion scanning using a Q-qQ linear ion trap (Q TRAP) Mass Spectrometer[J]. Rapid Commun Mass Spectrom, 2003, 17(10):1056-1064.

[19] Yao C, Feng Y L.A nontargeted screening method for covalent DNA adducts and DNA modification selectivity using liquid chromatography-tandem mass spectrometry[J]. Talanta, 2016, 159:93-102.

[20] Churchwell M I, Beland F A, Doerge D R.Quantification of O6-methyl and O6-ethyl deoxyguanosine adducts in C57BL/6N/Tk+/-mice using LC/MS/MS[J]. J Chromatogr B Anal Technol Biomed Life Sci, 2006, 844(1):60-66.

[21] Castro-Perez J, Plumb R, Liang L, et al.A highthroughput liquid chromatography/tandem mass spectrometry method for screening glutathione conjugates using exact mass neutral loss acquisition[J]. Rap Comm Mass Spectr, 2005, 19(6):798-804.

[22] Stanley L A.Drug Metabolism[M]. London, UK:Elsevier, 2017.

[23] Guo J, Villalta P W, Turesky R J.Data-independent mass spectrometry approach for screening and identification of DNA adducts[J]. Anal Chem, 2017, 89(21):11728-11736.

[24] Lu Z N, Luo Q, Zhao L N, et al.The mutational features of aristolochic acid-induced mouse and human liver cancers[J]. Hepatology, 2020, 71(3):929-942.

[25] Nortier J L, Martinez M, Schmeiser H H, et al.Urothelial carcinoma associated with the use of a Chinese herb[J]. New Engl J Med, 2000, 342(23):1686-1692.

[26] Arlt V M, Levova K, Barta F, et al.Role of P4501A1 and P4501A2 in bioactivation versus detoxication of the renal carcinogen aristolochic acid I:studies in Cyp1a1(-/-), Cyp1a2(-/-), and Cyp1a1/1a2(-/-) mice[J]. Chem Res Toxicol, 2011, 24(10):1710-1719.

[27] Chen C H, Dickman K G, Huang C Y, et al.Aristolochic acid-induced upper tract urothelial carcinoma in Taiwan:clinical characteristics and outcomes[J]. Int J Cancer, 2013, 133(1):14-20.

[28] 季文萱,杨成对,谌贻璞.马兜铃酸Ⅰ-DNA加合物合成及电喷雾质谱法检测[J]. 基础医学与临床, 2007(6):685-689.Ji W X, Yang C D, Shen Y P.Synthesis and electrospray mass spectrometric analysis of aristolochic acid Ⅰ-DNA adduct[J]. Bas Med Clinic Pract, 2007(6):685-689.

[29] Jelakovic B, Sandra K, Ivana V, et al.Aristolactam-DNA adducts are a biomarker of environmental exposure to aristolochic acid[J]. Kidney Int, 2012, 81(6):559-567.

[30] In IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans.polynuclear aromatic compounds, chemical, environmental and experimental data[J]. Int Agency Res Cancer, 1983, 32:211-224.

[31] Phillips D H.Fifty years of benzo (a) pyrene[J]. Nature, 1983, 303(5917):468-472.

[32] Hall M, Grover P L.Polycyclic Aromatic Hydrocarbons:Metabolism, Activation and Tumour Initiation[M]. Berlin Heidelberg:Chemical Carcinogenesis and Mutagenesis I, Springer Berlin Heidelberg, 1990, 327-372.

[33] Reactions of Polycyclic Aromatic Hydrocarbons with DNA.In DNA adducts:identification and biological significance IARC scientific publications[J]. Ag Res Cancer, 1994, 125:107-129.

[34] Frederick B A, Churchwell M I, von Tungeln L S, et al.High-performance liquid chromatog raphy electrospray ionization tandem mass spectrometry for the detection and quantitation of benzo[a]pyrene-DNA adducts[J]. Chem Res Toxicol, 2005, 18(8):1306-1315.

[35] Feng F, Wang X, Yuan H, et al.Ultra-performance liquid chromatography-tandem mass spectrometry for rapid and highly sensitive analysis of stereoisomers of benzo[a] pyrene diol epoxide-DNA adducts[J]. J Chromatogr B, 2009, 877(22):2104-2112.

[36] Rodgman A.Problems with the Tobacco Products Scientific Advisory Committee (TPSAC) list of harmful or potentially harmful tobacco and/or tobacco smoke components[J]. Beiträge zur Tabakforschung Int, 2011, 24(6):258-276.

[37] Agents Classified by the IARC Monographs[R]. Intenational Agency for Research on Cancer, 2012:1-110.

[38] Zhang S Y, Villalta P W, Wang M Y, et al.Analysis of crotonaldehyde-and acetaldehyde-derived 1, N²-propanodeoxyguanosine adducts in DNA from human tissues using liquid chromatography electrospray ionization tandem mass spectrometry[J]. Chem Res Toxicol, 2006, 19(10):1386-1392.

[39] Minko I G, Kozekov I D, Harris T M, et al.Chemistry and biology of DNA containing 1, N²-deoxyguanosine adducts of the ɑ, β-unsaturated aldehydes acrolein, crotonaldehyde, and 4-hydroxynonenal[J]. Chem Res Toxicol, 2009, 22(5):759-778.

[40] Stein S, Lao Y B, Yang I Y, et al.Genotoxicity of acetaldehyde-and crotonaldehyde-induced 1, N²-propanodeoxyguanosine DNA adducts in human cells[J]. Mutation Res, 2006, 608(1):1-7.

[41] Fernandes P H, Kanuri M, Nechev L V, et al.Mammalian cell mutagenesis of the DNA adducts of vinyl chloride and crotonaldehyde[J]. Env Mol Mutagen, 2005, 45(5):455-459.

[42] Budiawan E E.Detection of 1,N²-Propanodeoxyguanosine adducts in DNA of fischer 344 rats by an adapted ³²P-post-labeling technique after per os application of crotonaldehyde[J]. Carcinogenesis, 2000, 21(6):1191-1196.

[43] Foiles P G, Chung F L, Hecht S S.Development of a monoclonal antibody-based immunoassay for cyclic DNA adducts resulting from exposure to crotonaldehyde[J]. Cancer Res, 1987, 47(2):360-363.

[44] 刘鲁娟,李翔宇,陈欢,等.HPLC-MS/MS法检测巴豆醛暴露产生的DNA加合物[J]. 烟草科技, 2016, 49(9):63-69.Liu L J, Li X Y, Chen H, et al.Detection of DNA adducts induced by crotonaldehyde exposure with HPLC-MS/MS[J]. Tobac Sci Technol, 2016, 49(9):63-69.

[45] Wang M Y, Yu N X, Chen L, et al.Identification of an acetaldehyde adduct in human liver DNA and quantitation as N²-ethyldeoxyguanosine[J]. Chem Res Toxicol, 2006, 19(2):319-324.

[46] Inagaki S, Esaka Y, Deyashiki Y, et al.Analysis of DNA adducts of acetaldehyde by liquid chromatography-mass spectrometry[J]. J Chromatogr A, 2003, 987(1/2):341-347.

[47] Brooks P J, Zakhari S.Acetaldehyde and the Genome:Beyond Nuclear DNA Adducts and Carcinogenesis[J]. Env Mol Mutag, 2014, 55(2):77-91.

[48] Terashima I, Matsuda T, Fang T W, et al.Miscoding potential of the N²-ethyl-2'-deoxyguanosine DNA adduct by the exonuclease-free klenow fragment of Escherichia coli DNA polymerase I[J]. Biochemistry, 2001, 40(13):4106-4114.

[49] Garcia C C, Angeli J P, Freitas F P, et al.[¹³C2] -acetaldehyde promotes unequivocal formation of 1, N²-propano-2'-deoxyguanosine in human cells[J]. J Am Chem Soc, 2011, 133(24):9140-9143.

[50] Fang J L, Vaca C E.Development of a ³²P-postlabelling method for the analysis of adducts arising through the reaction of acetaldehyde with 2'-deoxyguanosine-3'-monophosphate and DNA[J]. Carcinogenesis, 1995, 16(9):2177-2185.

[51] 李木兰.典型醛类污染物与DNA形成加合物的机制及检测方法[D]. 衡阳:南华大学, 2005.Li M L.Mechanism and determination of DNA adducts formed by typical aldehyde pollutants with DNA[D]. Hengyang:Nanhua University, 2005.

[52] 刘鲁娟,李翔宇,陈欢,等.液相色谱-串联质谱法同时检测乙醛-DNA加合物[J]. 分析科学学报, 2017, 33(1):21-26.Liu L J, Li X Y, Chen H, et al.Simultaneous detection of acetaldehyde-DNA adducts by liquid chromatographytandem mass spectrometry[J]. Anal Sci, 2017, 33(1):21-26.

[53] Singh R, Gromadzinska J, Mistry Y, et al.Detection of acetaldehyde derived N⁽²⁾-ethyl-2'-deoxyguanosine in human leukocyte DNA following alcohol consumption[J]. Mutat Res, 2012, 737:8-11.

[54] Chen L, Wang M, Villalta P W, et al.Quantitation of an acetaldehyde adduct in human leukocyte DNA and the effect of smoking cessation[J]. Chem Res Toxicol, 2007, 20(1):108-113.

[55] Yin R, Liu S, Zhao C, et al.An ammonium bicarbonateenhanced stable isotope dilution UHPLC-MS/MS method for sensitive and accurate quantification of acrolein-DNA adducts in human leukocytes[J]. Anal Chem, 2013, 85(6):3190-3198.

[56] Vaissière T, Sawan C, Herceg Z.Epigenetic interplay between histone modifications and DNA methylation in gene silencing[J]. Mutat Res, 2008, 659(1/2):40-48.

[57] Jones P A, Baylin S B.The fundamental role of epigenetic events in cancer[J]. Nature Rev Gen, 2002, 3(6):415-428.

[58] 张宁,刘保东,汪海林.DNA加合物分析技术与方法[J]. 中国科学:化学, 2017, 47(12):1432-1444.Zhang N, Liu B, Wang H.Technology and methodology of DNA adducts analysis[J]. Sci Sin Chim, 2017, 47:1432-1444.

[59] Jones P A, Baylin S B.The epigenomics of cancer[J]. Cell, 2007, 128(4):683-692.

[60] Wang X, Suo Y, Yin R, et al.Ultra-performance liquid chromatography/tandem mass spectrometry for accurate quantification of global DNA methylation in human sperms[J]. J Chromatogr B Anal Technol Biomed Life Sci, 2011, 879(19):1647-1652.

[61] Yin R, Mao S Q, Zhao B, et al.Ascorbic acid enhances tet-mediated 5-methylcytosine oxidation and promotes DNA demethylation in mammals[J]. J Am Chem Soc, 2013, 135(28):10396-10403.

[62] Xiao S, Guo J, Yun B H, et al.Biomonitoring DNA adducts of cooked meat carcinogens in human prostate by nano liquid chromatography-high resolution tandem mass spectrometry:identification of 2-amino-1-methyl-6-phenylimidazo[4, 5-b]pyridine DNA adduct[J]. Anal Chem, 2016, 88(24):12508-12515.